You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Repurposing An Aging Facility To Produce Cell & Gene Therapies: Layout & Design Considerations

Aug 24, 2020

Repurposing a facility for cell and gene therapy production
Insights

Repurposing An Aging Facility To Produce Cell & Gene Therapies: Layout & Design Considerations

Aug 24, 2020

As we noted in Part 1 of this two-part article, many life sciences companies are shifting their operations to encompass new life-saving cell and gene therapy products, also known as advanced therapy medicinal products. In many cases, this requires converting legacy manufacturing facilities to produce these new therapies. In this installment, we will look at the basic design aspects to consider when renovating a facility to meet the unique demands of these therapies without compromising quality.

Modern cell therapy and biotech facilities have many basic requirements for continuous operation that need to be built into a robust facility. With future cell therapy and protein production, we are faced with small volumes, smaller working systems, higher value product, and potentially highly infectious materials.

The key consideration in any modern renovation is planning a space that accommodates the ICH/PICS guidelines, EU Annexes 1 and 2, and the FDA’s CFR 211. Due to the wide range of therapies, viral vectors, and bacterial organisms, the CDC’s guidelines for biosafety levels 1 and 2 (BL-1 and BL-2) and corresponding NIH design guides may also apply.

Ultimately, this leads us to a few basic concepts:

  • Large open processing suites with ample room to move processing skids in and out, as well as isolator systems for various cell processing
  • Space to stage volumes of disposables
  • Unidirectional flow of all personnel, materials, equipment, production, and waste
  • Segregation of all processing suites by air handling unit (AHU) to provide a robust facility
  • AHU zoning to contain any contamination within the suites
  • Air pressurization schemes in suites to contain BL-2 materials

Read the full article on CellAndGene.com.

Related Happenings At IPS

Share this Blog

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue